HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Single-dose antibiotic prophylaxis in high-risk patients undergoing cesarean section.

Abstract
A prospective, double-blind, placebo-controlled study was performed to determine the effectiveness of single-dose antibiotic prophylaxis in decreasing infectious complications after primary cesarean section. One hundred women at high risk for postoperative infectious morbidity were randomly assigned to receive either placebo or one 2-g dose of ceftizoxime at cord clamping. The incidence of endometritis in the antibiotic group was 6.0 versus 24.5% in the placebo group (P less than .05). The incidence of febrile morbidity in the group receiving one dose of ceftizoxime was 14.0 versus 32.7% in the placebo group (P less than .05). Single-dose ceftizoxime prophylaxis significantly reduced the incidence of endometritis and febrile morbidity in high-risk patients undergoing cesarean section.
AuthorsD H Saltzman, L J Eron, H H Kay, J G Sites
JournalObstetrics and gynecology (Obstet Gynecol) Vol. 65 Issue 5 Pg. 655-7 (May 1985) ISSN: 0029-7844 [Print] United States
PMID3885107 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
  • Ceftizoxime
  • Cefotaxime
Topics
  • Adult
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Cefotaxime (administration & dosage, analogs & derivatives, therapeutic use)
  • Ceftizoxime
  • Cesarean Section
  • Clinical Trials as Topic
  • Double-Blind Method
  • Female
  • Humans
  • Postoperative Complications (prevention & control)
  • Pregnancy
  • Premedication
  • Puerperal Infection (prevention & control)
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: